OOIR: Observatory of International Research

Papers

(The H4-Index of Blood Reviews is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Transplant-acquired allergy in HCT-recipients: Reference for clinical management	79
Pitfalls in laboratory monitoring of treatment in people with Haemophilia	78
Editorial Board	73
Practical guidance on the prevention and management of infection in multiple myeloma patients: A case-based approach	72
Radiation and leukaemia: Which leukaemias and what doses?	71
Artificial intelligence in sickle disease	63
Targeting CD38 in immune thrombocytopenia: Rationale and a scoping review of daratumumab	61
Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?	59
Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond	54
Thalassaemia in China	52
Not all LGL leukemias are created equal	50
Advances in the critical care management for patients with hematological malignancies	48
Addressing the challenges of accelerated and blast phase myeloproliferative neoplasms in 2022 and beyond	47
Targeting the neonatal Fc receptor (FcRn) in hematologic conditions with a focus on warm autoimmune hemolytic anemia	46
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma	45
Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk	45
Failure of CAR-T cell therapy in relapsed and refractory large cell lymphoma and multiple myeloma: An urgent unmet need	43
Chasing leukemia differentiation through induction therapy, relapse and transplantation	41
Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game	41
Corrigendum to “Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme” [Blood Rev. 2023 Sep:61:101103]	36
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT	35
Adenovirus infection in adult allogeneic hematopoietic stem cell transplant recipients: Systematic review and meta-analysis	35
Breaking down frailty: Assessing vulnerability in acute myeloid leukemia	33
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies	33
Harnessing multi-source data for individualized care in Hodgkin Lymphoma	32

Artificial intelligence in myeloid malignancies: Clinical applications of machine learning in myelodysplastic syndromes and acute myeloid Leukemia	32
Old tests and new paradigms: How to interpret iron studies and related biomarkers for the diagnosis of iron deficiency in adults	32
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs	32
Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and	31
Preservation of fertility in female patients with hematologic diseases	31
Gut microbiome composition and dysbiosis in immune thrombocytopenia: A review of literature	30